Mark Christianson, Business Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), sold 13,720 shares at $0.80 ($11K) on 2026-03-10, disclosed to the SEC on 2026-03-12.
Open-market sale of $11k NMTC by Business Development Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.80 | 11,611 | $9K | 84.6% |
| 2 | $0.80 | 2,109 | $2K | 15.4% |
| Total | $0.80 avg | 13,720 | $11K | 100% |
| Filing → |
| NMTC | SELL | 2026-03-16 | $734 | — | Filing → |
| NMTC | SELL | 2025-09-09 | $22K | — | Filing → |
| NMTC | SELL | 2025-06-05 | $6K | — | Filing → |